Erenumab is a medicine that helps prevent migraines in adults. It is a shot you give yourself under the skin once a month. It works by blocking the spot where a protein called CGRP attaches, which helps stop migraine attacks from starting.
Every report comes from a Lived member, sent anonymously.
Have you tried Aimovig (Erenumab) for Migraines?
Erenumab, sold as Aimovig, is a prescription medicine taken to prevent migraine in adults. It is meant to reduce how often migraine attacks happen, not to stop an attack that has already started, so people still keep a separate medicine for treating attacks. It is used for both episodic migraine (fewer than 15 headache days a month) and chronic migraine (15 or more headache days a month, at least 8 of them with migraine features). Erenumab was one of the first medicines designed specifically to prevent migraine. The older preventive medicines were developed for other conditions and only later adopted for migraine. The American Headache Society now considers erenumab and related medicines a first-line choice for prevention, meaning a person does not have to try and fail other preventive treatments first.
Erenumab is a monoclonal antibody, a laboratory-made protein that attaches to one precise target in the body. Its target is the receptor for CGRP (calcitonin gene-related peptide), a signaling molecule that nerves release and that research shows plays a key role in setting off migraine attacks. By sitting on the receptor, erenumab keeps CGRP from delivering its signal. A single injection is given once a month. Blocking CGRP lowers the chance that an attack gets started, which is why the effect shows up as fewer migraine days rather than as relief during an attack. It does not work for everyone, and researchers cannot yet predict who will respond best.
Erenumab is a single shot under the skin once a month, given in the belly, thigh or upper arm. It comes as a prefilled autoinjector pen or a prefilled syringe, and most people inject it themselves at home after being shown how. The usual dose is 70 mg a month; some people are prescribed 140 mg a month if they need a stronger effect. Keep the pens or syringes in the refrigerator in their carton. Take one out and let it sit at room temperature for at least 30 minutes before injecting, which helps deliver the full dose and makes the shot more comfortable; do not warm it in hot water or a microwave, and do not shake it. Once out of the fridge, a dose must be used within 7 days. If a monthly dose is missed, take it as soon as possible and then count the next month from that date.
Most people have few side effects. The most common are reactions where the shot was given, such as pain, redness or itching, and constipation. Muscle cramps or spasms are less common. Constipation can occasionally become severe enough to need hospital care or surgery, most often after the first dose but sometimes later. Contact the prescriber promptly about severe constipation, especially if other medicines that slow the bowel are also being taken. Allergic reactions such as a rash are usually mild, but serious reactions can happen, sometimes more than a week after a dose. Swelling of the face, lips, tongue or throat, or trouble breathing, needs emergency help right away. Anyone who has had a serious allergic reaction to erenumab should not take it again.
Erenumab can raise blood pressure or make existing high blood pressure worse. This was most often reported in the week after a dose, and many of the people affected already had high blood pressure or risk factors for it. People with hypertension may want to check their readings more closely when starting treatment and tell the prescriber about any rise. It can also bring on or worsen Raynaud's phenomenon, in which fingers or toes turn white or blue, cold and numb or painful, often in the cold or under stress. In reported cases with this type of medicine, symptoms appeared a couple of months after starting and some were severe. If these signs appear, stop the medicine and contact the prescriber; in most cases symptoms went away after stopping. People who already have Raynaud's should discuss this before starting. There is limited information about using erenumab during pregnancy or breastfeeding, so anyone pregnant, planning a pregnancy or nursing should weigh the choice with their clinician. Share a full medicine list, including laxatives and anything that causes constipation.
Erenumab works gradually across monthly doses. In the main studies, results were measured after three to six months. Among adults with about 8 migraine days a month, those on erenumab had roughly 3 to 4 fewer migraine days a month, compared with about 2 fewer on a placebo shot, and around half cut their migraine days at least in half. In adults with chronic migraine, the drop was about 6 to 7 days a month compared with about 4 on placebo. People also tended to need their attack medicines on fewer days. A headache diary showing migraine days and attack medicine use makes it easier to tell whether treatment is helping. If the result is not worthwhile after a fair trial, the prescriber may raise the dose, switch to a related medicine or try a different approach. People who benefit often continue for long periods, with regular reviews of whether treatment is still needed.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Aimovig (Erenumab), what you've noticed, or ask the community a question.